DSC_6739
Tuesday, June 2, 2026
29.9
C
Bengaluru
Hot topics
Time for Pharma to Re-think its Way of Working
https://www.youtube.com/watch?v=BOO_CNxEzwQ
Too many Medical Reps are chasing too few doctors,...
Arjun Arunachalam: The Man Who Deleted Helium
For more than fifty years, the MRI industry treated...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Going Digital – What Indian Pharma C-Suite has to Say
Any transformational initiative must be driven by the CEO...
Semaglutide – More Than Just a Patent Battle
The Delhi High Court has restrained Dr. Reddy’s and...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Hot topics
Biocon Biologics Scores FDA Approval—A Biosimilar Shake-Up for Amgen, Patients, and Investors
Biocon Biologics secures FDA approval for Bosaya™ and Aukelso™,...
American Tariffs and The Rise of the Corporate Superpower
From Nation-States to Corporate Titans: How Innovation is Redrawing...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Newsletter
Get important news delivered directly to your inbox and stay connected!